CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-31 | Kavanaugh William Michael Chief Scientific Officer and | Option exercise | +8,917 | $6.61 | $59K | 13,917 |
| 2015-12-31 | Kavanaugh William Michael Chief Scientific Officer and | Option exercise · Employee Stock Option (right to buy) | −8,917 | 76,688 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion | +8,670,351 | 8,670,351 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion · Series B-1 Preferred Stock | −8,105,314 | 0 | ||
| 2015-10-14 | THIRD ROCK VENTURES LP 10% owner | Conversion · Series C Preferred Stock | −565,037 | 0 | ||
| 2015-10-14 | LADD CYNTHIA J Senior VP and General Counsel | Purchase | +3,000 | $12.00 | $36K | 3,000 |
| 2015-10-14 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Purchase | +5,000 | $12.00 | $60K | 5,000 |
| 2015-10-14 | SHANNON TIMOTHY M Director | Conversion | +3,566,337 | 3,566,337 | ||
| 2015-10-14 | SHANNON TIMOTHY M Director | Conversion | +1,318,418 | 1,318,418 | ||
| 2015-10-14 | SHANNON TIMOTHY M Director | Conversion · Series B-1 Convertible Preferred Stock | −3,566,337 | 0 | ||
| 2015-10-14 | SHANNON TIMOTHY M Director | Conversion · Series C Convertible Preferred Stock | −1,318,418 | 0 | ||
| 2015-10-14 | GLUCK FREDERICK W Director | Purchase | +10,000 | $12.00 | $120K | 147,791 |
| 2015-10-14 | GLUCK FREDERICK W Director | Purchase | +5,000 | $12.00 | $60K | 5,000 |
| 2015-10-14 | Canaan IX L.P. Director | Conversion | +4,884,755 | 4,884,755 | ||
| 2015-10-14 | Canaan IX L.P. Director | Conversion · Series B-1 Redeemable Convertible Preferred Stock | −3,566,337 | 0 | ||
| 2015-10-14 | Canaan IX L.P. Director | Conversion · Series C Redeemable Convertible Preferred Stock | −1,318,418 | 0 | ||
| 2015-10-14 | Flynn James E 10% owner | Conversion | +160,512 | 160,512 | ||
| 2015-10-14 | Flynn James E 10% owner | Conversion | +160,512 | 160,512 | ||
| 2015-10-14 | Flynn James E 10% owner | Purchase | +510,512 | $12.00 | $6.1M | 671,024 |
| 2015-10-14 | Flynn James E 10% owner | Purchase | +114,488 | $12.00 | $1.4M | 275,000 |
Page 32 of 33 · 649 trades